MMRGlobal Adds Health Information Technology Patents in Korea, Mexico & New Zealand

LOS ANGELES, CA--(Marketwired - Dec 16, 2014) - MMRGlobal, Inc. (OTCQB: MMRF), through its wholly-owned subsidiary, MyMedicalRecords, Inc. (collectively "MMR" or the "Company"), today announced four new health information technology patents which are to issue including two patents in South Korea and additional patents in Mexico and New Zealand. MMR is a practicing entity and a leading provider of Personal Health Records ("PHRs") through its patented MyMedicalRecords product and service offerings. Robert H. Lorsch, Chairman and CEO of MMRGlobal, said, "The Company continues to add numerous patents both domestically and internationally in tandem with the revolution in health information technology happening all over the world. MMR is well positioned for the future of healthcare today as millions of consumers become engaged in better managing their care by tracking their personal health information."

The Company has been notified that the Korean Intellectual Property Office (KIPO) has allowed Patent Application No. 10-2010-7025779, entitled "Method and System for Providing Online Medical Records," and Patent Application No. 10-2008-7008445, also entitled "Method and System for Providing Online Medical Records." The allowed patent applications include 41 and 36 claims, respectively, for a total of 77 claims. The claims are directed toward accessing and collecting health records through a secure Web site which include amongst other things fax and voice communications. Claims also include features to manage prescriptions, calendaring prescription refills, sending prescription refill reminders as well as managing appointments with healthcare providers, and additional features associated with Personal Health Records. The resulting patents will be the Company's first and second issued patent in South Korea.

MMR has also recently been notified that the New Zealand Intellectual Property Office has agreed that the patent application entitled "Method and System for Managing Personal Health Records with Telemedicine and Health Monitoring Device Features," IP Number 627,858, is approved for acceptance. This application includes 21 claims directed toward generating Personal Health Records from patient monitoring devices and sharing these records with healthcare providers.

Additionally, MMR has been notified that the Mexican Industrial Property Institute (IMPI) has issued an official Notice of Allowance for Mexican Patent Application No. MX/a/2013/003650 entitled "Universal Patient Record Conversion Tool." The allowed patent application includes 15 claims directed to a system which allows patient data from practice management systems to be seamlessly uploaded into a healthcare provider portal system. MMR offers this tool as the Practice Management System Integration Application (PMSIA), which allows administrators in physician offices, hospitals and alternative care sites to facilitate the efficient population of patient information from a healthcare provider's practice management system to other Electronic Medical Record systems including the Company's MMRPro Web-based application.

"This universal tool represents a way that can help accelerate the growth of health information technology while allowing a faster, more efficient integration of Electronic Medical Records into any healthcare professional's office, opening the door for MMRGlobal to position its products with competitive EHR systems and potentially creating opportunities for incremental licensing revenue," added Lorsch.

MyMedicalRecords, Inc., with products available in both English and Spanish, is a leading provider of secure and easy-to-use Personal Health Records through its MyMedicalRecords PHR, and MMRPro document management and imaging systems for healthcare professionals. MMR also provides the MyEsafeDepositBox solution which provides an online site to securely store important legal, financial, insurance and other important documents, as well as medical and personal health information. MMR currently has 13 issued U.S. health IT patents including U.S. Patent Nos. 8,301,466; 8,352,287; 8,352,288; 8,121,855; 8,117,646; 8,117,045; 8,321,240; 8,498,883; 8,626,532, 8,645,161; 8,725,537; 8,768,725 and 8,775,212, as well as additional applications and continuation applications involving inventions pertaining to Personal Health Records, Patient Portals and other Electronic Health Record systems. In addition to the U.S., MMR has patents issued, pending and/or applied for in 11 other countries or regional authorities of commercial interest including Australia, Singapore, New Zealand, Mexico, Japan, Canada, Hong Kong, China, South Korea, Israel and Europe.

About MMRGlobal, Inc.
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of the Company's products and services at www.mmrtheater.com. Follow us on Facebook.com/MMRGlobal and Twitter.com/mmrglobal.

Forward-Looking Statements
All statements in this release that are not strictly historical facts are "forward-looking statements." Such forward-looking statements are based on MMR's current assumptions, beliefs and expectations, and involve risks, uncertainties and other factors that may cause MMR's actual results to be materially different from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words such as "expect," "plan," "possibility," "offer," "if," "negotiate," "when," "believe," "will," "estimate," "continue," and similar expressions. Risks, uncertainties, and other factors that could cause or contribute to such differences include, but are not limited to: ongoing and future intellectual property enforcement actions; the ability to successfully litigate or settle claims of patent infringement; MMR's ability to develop, license and monetize its patent and the additional patents in the portfolio for both MMR's health IT and biotechnology IP assets; reliance upon the successful operations of its business partners in selling MMR's products and services, the timing of milestone payments in connection with licensing its IP; MMR's ability to obtain necessary financing, generate sufficient cash flow, and maintain appropriate indebtedness; and the increasing development of market competition in the area of electronic records in clinical trials. These factors and others are described in more detail in MMR's public filings with the Securities and Exchange Commission, including the risks discussed in the "Risk Factors" section in MMR's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Copies of these reports can be found on MMR's website (www.mmrglobal.com) under the heading "Investor Relations." MMR is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained herein as a result of new information, future events or otherwise.